Markets:

Overview

News

Currencies

International

Treasuries

Progyny, Inc. - Common Stock (NQ:PGNY)

21.32 -0.20 (-0.93%)

Streaming Delayed Price Updated: 12:33 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

3 Russell 2000 Stocks We Think Twice About

January 29, 2026

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Progyny Inc (NASDAQ:PGNY) Combines Strong Fundamentals with Bullish Technical Setup ↗

January 27, 2026

Via Chartmill

Progyny (PGNY) Stock Is Up, What You Need To Know

January 20, 2026

Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.3% in the afternoon session after Citizens upgraded the fertility benefits company's stock from Market Perform to Market Outperform,...

Via StockStory

Topics Artificial Intelligence Supply Chain

1 Profitable Stock to Consider Right Now and 2 We Avoid

January 15, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

3 Hyped Up Stocks That Concern Us

January 14, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

January 12, 2026

Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial Guidance

From Progyny, Inc.

Via GlobeNewswire

Progyny (PGNY) Stock Is Up, What You Need To Know

January 08, 2026

Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 4.9% in the morning session after an analyst at Keybanc maintained a positive rating on the stock and raised its price target.

Via StockStory

Topics Artificial Intelligence Economy Supply Chain

2 Reasons PGNY is Risky and 1 Stock to Buy Instead

December 31, 2025

Over the past six months, Progyny has been a great trade, beating the S&P 500 by 5.2%. Its stock price has climbed to $25.68, representing a healthy 16.4% increase. This was partly thanks to its solid...

Via StockStory

Topics Economy Stocks Supply Chain

3 Small-Cap Stocks with Warning Signs

December 23, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Topics Bonds

1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore

December 21, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

PROGYNY INC (NASDAQ:PGNY) Emerges as a Top Affordable Growth Stock Pick ↗

December 20, 2025

PROGYNY (PGNY) exemplifies the GARP strategy with strong earnings growth, a fair PEG ratio, and a robust, debt-free balance sheet.

Via Chartmill

3 Healthcare Stocks We Approach with Caution

December 18, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

3 Healthcare Stocks We’re Skeptical Of

December 16, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 15.6% over...

Via StockStory

Topics Stocks

3 Cash-Heavy Stocks That Fall Short

December 11, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

1 Russell 2000 Stock with Impressive Fundamentals and 2 Facing Headwinds

December 08, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

2 Stocks Under $50 on Our Watchlist and 1 We Find Risky

December 07, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

3 Value Stocks We Find Risky

December 04, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

3 Hyped Up Stocks Walking a Fine Line

December 03, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

CEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too? ↗

December 02, 2025

Is the CEO's latest purchase a buy signal for investors?

Via The Motley Fool

Topics Regulatory Compliance

Progyny (PGNY) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Progyny (PGNY) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

November 21, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action

November 20, 2025

75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to...

From Progyny, Inc.

Via GlobeNewswire

A Look Back at Health Insurance Providers Stocks’ Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack

November 17, 2025

Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q3 health insurance providers earnings season.

Via StockStory

Topics Artificial Intelligence Economy Fraud

5 Must-Read Analyst Questions From Progyny’s Q3 Earnings Call

November 13, 2025

Progyny’s third quarter was marked by strong top-line and profitability outperformance, which drew a positive market response. Management attributed these results to robust new client acquisition, the...

Via StockStory

Topics Earnings Workforce

3 Inflated Stocks with Warning Signs

November 12, 2025

Via StockStory

This AT&T Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

November 12, 2025

Via Benzinga

Why Progyny Stock Is Soaring Today ↗

November 07, 2025

Progyny generates nearly $200 million in free cash flow annually and holds over $300 million in cash, yet it has a market cap of only $1.9 billion. It could be a bargain as stock-based compensation...

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum

November 07, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.